BIOMAT Database Logo BIOMAT Database Logo

Chronic hyperplastic candidosis and secretor status. 1991

P J Lamey, and A M Darwazeh, and J Muirhead, and J S Rennie, and L P Samaranayake, and T W MacFarlane
Department of Oral Medicine and Pathology, Glasgow Dental Hospital and School, Scotland.

A prospective study was undertaken of 22 patients with chronic hyperplastic candidosis and 50 age and sex matched individuals with no evidence of oral mucosal disease. Specifically the relationship between the inherited ability to secrete blood group antigens in saliva and chronic hyperplastic candidosis was investigated. The proportion of non-secretors of blood group antigens was significantly higher in patients with chronic hyperplastic candidosis (68%) compared to the control subjects (38%). The inability to secrete blood group antigens in saliva may therefore be a risk factor in the development of, or persistence of chronic hyperplastic candidosis.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D007972 Leukoplakia, Oral A white patch seen on the oral mucosa. It is considered a premalignant condition and is often tobacco-induced. When evidence of Epstein-Barr virus is present, the condition is called hairy leukoplakia (LEUKOPLAKIA, HAIRY). Keratosis, Oral,Leukokeratosis, Oral,Keratoses, Oral,Leukokeratoses, Oral,Leukoplakias, Oral,Oral Keratoses,Oral Keratosis,Oral Leukokeratoses,Oral Leukokeratosis,Oral Leukoplakia,Oral Leukoplakias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002180 Candidiasis, Oral Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed) Moniliasis, Oral,Thrush,Candidiases, Oral,Moniliases, Oral,Oral Candidiases,Oral Candidiasis,Oral Moniliases,Oral Moniliasis
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000017 ABO Blood-Group System The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. ABH Blood Group,ABO Blood Group,ABO Factors,Blood Group H Type 1 Antigen,H Blood Group,H Blood Group System,ABO Blood Group System,Blood Group, ABH,Blood Group, ABO,Blood Group, H,Blood-Group System, ABO,Factors, ABO,System, ABO Blood-Group

Related Publications

P J Lamey, and A M Darwazeh, and J Muirhead, and J S Rennie, and L P Samaranayake, and T W MacFarlane
Oral medicine: Chronic hyperplastic candidosis.
June 2018, British dental journal,
P J Lamey, and A M Darwazeh, and J Muirhead, and J S Rennie, and L P Samaranayake, and T W MacFarlane
Chronic hyperplastic candidosis/candidiasis (candidal leukoplakia).
January 2003, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists,
P J Lamey, and A M Darwazeh, and J Muirhead, and J S Rennie, and L P Samaranayake, and T W MacFarlane
Expression of alpha-defensin-1 in chronic hyperplastic candidosis.
July 2005, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
P J Lamey, and A M Darwazeh, and J Muirhead, and J S Rennie, and L P Samaranayake, and T W MacFarlane
Phenotypic characterisation of Candida albicans isolated from chronic hyperplastic candidosis.
February 2000, Journal of medical microbiology,
P J Lamey, and A M Darwazeh, and J Muirhead, and J S Rennie, and L P Samaranayake, and T W MacFarlane
Differential expression of Toll-like receptors in chronic hyperplastic candidosis.
August 2008, Oral microbiology and immunology,
P J Lamey, and A M Darwazeh, and J Muirhead, and J S Rennie, and L P Samaranayake, and T W MacFarlane
Immunohistochemical Expression Patterns of Inflammatory Cells Involved in Chronic Hyperplastic Candidosis.
November 2019, Pathogens (Basel, Switzerland),
P J Lamey, and A M Darwazeh, and J Muirhead, and J S Rennie, and L P Samaranayake, and T W MacFarlane
Expression of interleukin-8 and its receptor IL-8RA in chronic hyperplastic candidosis.
August 2006, Oral microbiology and immunology,
P J Lamey, and A M Darwazeh, and J Muirhead, and J S Rennie, and L P Samaranayake, and T W MacFarlane
Chronic hyperplastic candidosis: a pilot study of the efficacy of 0.18% isotretinoin.
September 2009, Journal of oral science,
P J Lamey, and A M Darwazeh, and J Muirhead, and J S Rennie, and L P Samaranayake, and T W MacFarlane
A possible CD1a Langerhans cell-mast cell interaction in chronic hyperplastic candidosis.
July 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
P J Lamey, and A M Darwazeh, and J Muirhead, and J S Rennie, and L P Samaranayake, and T W MacFarlane
Concurrent chronic hyperplastic candidosis and oral lichenoid lesion as adverse events of secukinumab therapy.
September 2021, Australian dental journal,
Copied contents to your clipboard!